Abstract
Twenty-eight acyl hydrazides (1-28) are subjected for nitric oxide scavenging activities and their structureactivity relationship (SAR) is established. Compounds 1-28 showed a varying degree of activity having IC50 values in the range of 9.1 ± 6.5 - 231.1 μM. It was found that twenty-five (25) out of twenty-eight (28) compounds, showed an excellent nitric oxide scavenging activity. It was observed that the activity mainly depends on the substitution on acyl hyrazide moiety. 3-Propylpyrozole-5-carbohydrazide (27) was found to be the most active in the series with an IC50 value of 9.1 μM. Thus, compound 27 may serve as a lead compound for further development as potent antioxidant agent.
Keywords: Acyl hydrazides, Free radicals, Reactive oxygen species (ROS), Nitric oxides scavengers, Antioxidant, Lead molecules, peroxynitrite, tonic relaxation, antitumor, antiglycation, antituberculosis, Nitroprusside sodium, heterocyclic, radical-scavenging, antimicrobial, conventional synthetic methods
Letters in Drug Design & Discovery
Title: Acyl Hydrazides: Potent Antioxidants
Volume: 9 Issue: 2
Author(s): Khalid Mohammed Khan, Mubeen Rani, Nida Ambreen, Asma Ejaz, Shahnaz Perveen, Syed Moazzam Haider, Mohammad Iqbal Choudhary and Wolfgang Voelter
Affiliation:
Keywords: Acyl hydrazides, Free radicals, Reactive oxygen species (ROS), Nitric oxides scavengers, Antioxidant, Lead molecules, peroxynitrite, tonic relaxation, antitumor, antiglycation, antituberculosis, Nitroprusside sodium, heterocyclic, radical-scavenging, antimicrobial, conventional synthetic methods
Abstract: Twenty-eight acyl hydrazides (1-28) are subjected for nitric oxide scavenging activities and their structureactivity relationship (SAR) is established. Compounds 1-28 showed a varying degree of activity having IC50 values in the range of 9.1 ± 6.5 - 231.1 μM. It was found that twenty-five (25) out of twenty-eight (28) compounds, showed an excellent nitric oxide scavenging activity. It was observed that the activity mainly depends on the substitution on acyl hyrazide moiety. 3-Propylpyrozole-5-carbohydrazide (27) was found to be the most active in the series with an IC50 value of 9.1 μM. Thus, compound 27 may serve as a lead compound for further development as potent antioxidant agent.
Export Options
About this article
Cite this article as:
Mohammed Khan Khalid, Rani Mubeen, Ambreen Nida, Ejaz Asma, Perveen Shahnaz, Moazzam Haider Syed, Iqbal Choudhary Mohammad and Voelter Wolfgang, Acyl Hydrazides: Potent Antioxidants, Letters in Drug Design & Discovery 2012; 9 (2) . https://dx.doi.org/10.2174/157018012799079798
DOI https://dx.doi.org/10.2174/157018012799079798 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From Biomarkers to Cytokine-like Hormones: Uncovering New Directives for Cognitive Loss and Alzheimer’s Disease
Current Neurovascular Research Microbe-Host Interactions: Structure and Role of Gram-Negative Bacterial Porins
Current Protein & Peptide Science The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies
Central Nervous System Agents in Medicinal Chemistry Meet Our Regional Editor
Current Vascular Pharmacology The Future of Neuroregenerative Therapy for Parkinson’s Disease
Current Tissue Engineering (Discontinued) Biomarker Metabolite Signatures Pave the Way for Electronic-nose Applications in Early Clinical Disease Diagnoses
Current Metabolomics Statins and Elderly: From Clinical Trials to Daily Practice
Current Vascular Pharmacology Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
Current Medicinal Chemistry The Economics of Pharmacogenomics
Current Pharmacogenomics The Role of LRRK2 in Neurodegeneration of Parkinson Disease
Current Neuropharmacology An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect
Current Pharmaceutical Biotechnology Heart Rate Variability Based Prediction of Personalized Drug Therapeutic Response: The Present Status and the Perspectives
Current Topics in Medicinal Chemistry Postprandial Hypotension - Novel Insights into Pathophysiology and Therapeutic Implications
Current Vascular Pharmacology The Failure of Immunomodulation Therapy in Heart Failure: Does the Statins “Paradigm” Prove the Rule?
Current Vascular Pharmacology Epigenetic Basis of Neuronal and Synaptic Plasticity
Current Topics in Medicinal Chemistry Meta-Analysis of Creatine for Neuroprotection Against Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets The Etiology of Hypertension in the Metabolic Syndrome Part One: An Introduction to the History, the Concept and the Models
Current Vascular Pharmacology The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2
Cardiovascular & Hematological Disorders-Drug Targets Review: Therapeutic Targeting of HMGB1 in Stroke
Current Drug Delivery Cardiac Regeneration: Stem Cells and Beyond
Current Medicinal Chemistry